WARD Surgery RCT II

WARD Surgery RCT II

Principal Investigator

Jesper Mølgaard, MD, PhD student

Study design
Randomized controlled trial
Sample size
504 participants
Study sites

Rigshospitalet, Bispebjerg Hospital and Hvidovre Hospital

Inclusion criteria
  • Admission for elective major abdominal (gastrointestinal, gynecological, or urological) surgery with the primary aim of radical surgery/removing suspected cancer tissue.
  • At least two expected postoperative admission days
  • Laparotomy or laparoscopy procedure estimated to last more than 2 hours.
  • Co-enrolment of patients in other studies is acceptable but in studies involving interventions which potentially will affect the continuous monitoring of vital signs and/or the primary or secondary outcomes, an assessment of whether these patients can be co-enrolled in the WARD-RCT should be conferred with the WARD RCT steering committee.
Study procedures

Continuous wireless recording of vital values with patients randomized to either no monitoring, or nurse based monitoring of a mobile phone app with vital signs displayed and alerts for sustained deviations.

Outcome

Adverse events and serious adverse events. Days alive and out of hospital.

Trial registration
NCT06269198

–  Read more